Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Zymeworks Completes Acquisition of Theravance Biopharma; Updates 2026 Guidance

Zymeworks Completes Acquisition of Theravance Biopharma; Updates 2026 Guidance

MT newswireMT newswire2026/09/28 10:33
06:33 AM EDT, 09/28/2026 (MT Newswires) -- Zymeworks (ZYME) said Monday it has completed its acquisition of Theravance Biopharma, adding Yupelri, a treatment for the long-term maintenance of chronic obstructive pulmonary disease, to its portfolio. The company said it expects 2026 revenue of $278 million to $292 million, including collaboration revenue from Yupelri. Yupelri, marketed through Theravance's partnership with Viatris, generated $133.1 million in sales in H1 2026. Zymeworks said it is entitled to 35% of net US profits from the drug and royalties on sales outside the US. The acquisition was financed with a $350 million non-recourse loan from OMERS Life Sciences and about $217.5 million of Zymeworks' cash. Zymeworks said it expects acquisition and restructuring-related costs of about $25 million to $30 million. It also expects a potential $100 million milestone payment related to Trelegy Ellipta in Q1 2027, subject to the milestone being met.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Bank of Japan Governor: Wage growth is "quite strong," next year's spring shunto negotiations will be a key variable

The minutes of the Bank of Japan show that Governor Kazuo Ueda said recent wage growth has been "quite strong," in line with the 2% inflation target. Next year's wage negotiations and cost pass-through will be key factors for policy.

智通财经•2026/11/16 09:24
Bank of Japan Governor: Wage growth is "quite strong," next year's spring shunto negotiations will be a key variable